Home
COMPANY
Cingulate® (CTx®) is a biopharmaceutical company focused on the development of new product candidates for the treatment of central nervous system and neurobiological disorders.
PIPELINE
Cingulate® currently has two product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
ADHD
Attention Deficit/Hyperactivity Disorder (ADHD) is a chronic neurobiological and developmental disorder that affects millions of children and often continues into adulthood.
ANXIETY
Anxiety is the feeling of fear that occurs when faced with threatening or stressful situations or can be endogenous and not have an identified stressor.
The Precision Timed Release™ Platform
The Precision Timed Release™ Platform is a triad of proprietary, sophisticated elements
- Proprietary Erosion Barrier Layer (EBL)
- Specialized compression technology
- Semi-continuous manufacturing & real-time release
Computed Tomography Scan (CT scan) of CTx-1301 tablet
ANXIETY
Anxiety is the feeling of fear that occurs when faced with threatening or stressful situations or can be endogenous and not have an identified stressor.